MA29873B1 - Composes - Google Patents

Composes

Info

Publication number
MA29873B1
MA29873B1 MA30851A MA30851A MA29873B1 MA 29873 B1 MA29873 B1 MA 29873B1 MA 30851 A MA30851 A MA 30851A MA 30851 A MA30851 A MA 30851A MA 29873 B1 MA29873 B1 MA 29873B1
Authority
MA
Morocco
Prior art keywords
compounds
antibacterial agents
tricyclic nitrogen
nitrogen compounds
tricyclic
Prior art date
Application number
MA30851A
Other languages
English (en)
Inventor
Nathalie Cailleau
David Thomas Davies
Joel Michael Esken
Alan Joseph Hennessy
Sukumar Senthil Kumar Kusalakumari
Roger Edward Markwell
Timothy James Miles
Neil David Pearson
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of MA29873B1 publication Critical patent/MA29873B1/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06Peri-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D519/00Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Composés Composés azotés tricycliques et leur utilisation comme agents antibactériens.
MA30851A 2005-10-21 2008-04-15 Composes MA29873B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72897505P 2005-10-21 2005-10-21
US82659006P 2006-09-22 2006-09-22

Publications (1)

Publication Number Publication Date
MA29873B1 true MA29873B1 (fr) 2008-10-03

Family

ID=38256822

Family Applications (1)

Application Number Title Priority Date Filing Date
MA30851A MA29873B1 (fr) 2005-10-21 2008-04-15 Composes

Country Status (27)

Country Link
US (2) US20080280892A1 (fr)
EP (1) EP1954697B1 (fr)
JP (1) JP2009512695A (fr)
KR (1) KR20080064173A (fr)
AR (1) AR057981A1 (fr)
AT (1) ATE458737T1 (fr)
AU (1) AU2006335042A1 (fr)
BR (1) BRPI0617467A2 (fr)
CA (1) CA2626641A1 (fr)
CR (1) CR9930A (fr)
CY (1) CY1110137T1 (fr)
DE (1) DE602006012535D1 (fr)
DK (1) DK1954697T3 (fr)
EA (1) EA200801128A1 (fr)
ES (1) ES2340531T3 (fr)
HK (1) HK1118546A1 (fr)
HR (1) HRP20100194T8 (fr)
IL (1) IL190803A0 (fr)
MA (1) MA29873B1 (fr)
NO (1) NO20082191L (fr)
NZ (1) NZ567315A (fr)
PE (1) PE20070793A1 (fr)
PL (1) PL1954697T3 (fr)
PT (1) PT1954697E (fr)
SI (1) SI1954697T1 (fr)
TW (1) TW200736263A (fr)
WO (1) WO2007081597A2 (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2626641A1 (fr) * 2005-10-21 2007-07-19 Glaxo Group Limited Composes
US20070185153A1 (en) 2005-12-22 2007-08-09 Nathalie Cailleau Compounds
ATE481406T1 (de) 2006-04-06 2010-10-15 Glaxo Group Ltd Pyrrolochinoxalinonderivate als antibakterielle mittel
GB0608263D0 (en) 2006-04-26 2006-06-07 Glaxo Group Ltd Compounds
GB0613208D0 (en) * 2006-07-03 2006-08-09 Glaxo Group Ltd Compounds
GB0705672D0 (en) * 2007-03-23 2007-05-02 Glaxo Group Ltd Compounds
CL2008001002A1 (es) 2007-04-11 2008-10-17 Actelion Pharmaceuticals Ltd Compuestos derivados de oxazolidinona; composicion farmaceutica que comprende a dichos compuestos; y su uso para preparar un medicamento para tratar una infeccion bacteriana.
DE602008002912D1 (de) * 2007-04-20 2010-11-18 Glaxo Group Ltd Tricyclische stickstoffhaltige verbindungen als antibakterielle wirkstoffe
GB0707706D0 (en) * 2007-04-20 2007-05-30 Glaxo Group Ltd Compounds
EP2005995A1 (fr) * 2007-06-22 2008-12-24 Glaxo Group Limited Composés hétérocycliques pour le traitement de la tuberculose
EP2080761A1 (fr) 2008-01-18 2009-07-22 Glaxo Group Limited Composés
US8349828B2 (en) 2008-02-20 2013-01-08 Actelion Pharmaceuticals Ltd. Azatricyclic antibiotic compounds
CA2720672A1 (fr) 2008-04-15 2009-10-22 Actelion Pharmaceuticals Ltd Antibiotiques tricycliques
CN102105467A (zh) 2008-08-04 2011-06-22 埃科特莱茵药品有限公司 三环烷氨基甲基噁唑烷酮衍生物
RU2530884C2 (ru) * 2008-10-07 2014-10-20 Актелион Фармасьютиклз Лтд Трициклические оксазолидиноновые антибиотические соединения
JP2012505866A (ja) * 2008-10-17 2012-03-08 グラクソ グループ リミテッド 抗菌剤として使用される三環式窒素化合物
NZ593891A (en) 2008-12-12 2013-05-31 Actelion Pharmaceuticals Ltd 5-amino-2-(1-hydroxy-ethyl)-tetrahydropyran derivatives
WO2010081874A1 (fr) 2009-01-15 2010-07-22 Glaxo Group Limited Composés naphthyridine-2(1h)-one utiles comme antibactériens
TW201313726A (zh) 2011-09-16 2013-04-01 Actelion Pharmaceuticals Ltd 製造合成之中間體之方法
US9029368B2 (en) 2011-11-30 2015-05-12 Actelion Pharmaceuticals Ltd. 3,7-disubstituted octahydro-2H-pyrido[4,3-E][1,3]oxazin-2-one antibiotics
SG11201700566SA (en) 2014-08-22 2017-03-30 Glaxosmithkline Ip Dev Ltd Tricyclic nitrogen containing compounds for treating neisseria gonorrhoea infection
WO2018159609A1 (fr) 2017-02-28 2018-09-07 三井化学アグロ株式会社 Composition de prévention de maladies des plantes et procédé de prévention de maladies des plantes l'utilisant
WO2018207023A2 (fr) * 2017-05-10 2018-11-15 Albajuna Therapeutics, S.L. Dérivés de protéine de fusion fc présentant une double activité élevée immunomodulatrice et antivirale contre le vih
JP2023506147A (ja) 2019-12-02 2023-02-15 ストーム・セラピューティクス・リミテッド Mettl3阻害剤としてのポリヘテロ環式化合物
AU2020397059A1 (en) 2019-12-06 2022-07-21 Vertex Pharmaceuticals Incorporated Substituted tetrahydrofurans as modulators of sodium channels

Family Cites Families (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3323868A (en) * 1961-12-14 1967-06-06 Laporte Chemical Manufacture of hydrogen peroxide
BE634031A (fr) * 1962-06-23
GB1394373A (en) * 1972-05-17 1975-05-14 Pfizer Ltd Control of plant diseases
US4066706A (en) * 1975-04-21 1978-01-03 Halcon International, Inc. Preparation of ethylbenzene hydroperoxide
DE2805915C3 (de) * 1978-02-13 1981-11-05 Dynamit Nobel Ag, 5210 Troisdorf Reaktor zur Oxidation von Gemischen aus p-Xylol und p-Toluylsäuremethylester mit sauerstoffhaltigen Gasen in flüssiger Phase
DE2914218C2 (de) * 1978-04-12 1985-10-24 Otsuka Pharmaceutical Co. Ltd., Tokio/Tokyo N-Acylderivate des Ampicillins und Amoxicillins, Verfahren zu deren Herstellung und pharmazeutische Zubereitungen, welche die Verbindungen enthalten
US4416884A (en) * 1978-04-12 1983-11-22 Otsuka Pharmaceutical Co., Ltd. Piperazinylbenzoheterocyclic compounds
NO156828C (no) * 1980-11-10 1987-12-02 Otsuka Pharma Co Ltd Analogifremgangsm te for fremstilling av antibakterielt virksomme benzoheterocykliske forbindelser.
US4595755A (en) * 1982-03-25 1986-06-17 Ciba-Geigy Corporation 5-halo-1,2,3-(1,2-dihydropyrrolo)-4-quinolones
ATE21514T1 (de) * 1982-03-25 1986-09-15 Ciba Geigy Ag Verfahren zur herstellung von 1,2,5,6-tetrahydro4h-pyrrolo(3,2,1-ij)-chinolin-4-on und neue 5ch820325
US4443447A (en) * 1982-10-25 1984-04-17 Riker Laboratories, Inc. Phenyl-substituted tricyclic antibacterial agents
US4603199A (en) * 1982-10-25 1986-07-29 Riker Laboratories, Inc. Phenyl-substituted tricyclic antibacterial agent intermediates
US6121285A (en) * 1995-11-22 2000-09-19 Daiichi Pharmaceutical Co., Ltd. Substituted aminocycloalkylpyrrolidine derivatives and cis-substituted aminocycloalkylpyrrolidine derivatives
GB9622386D0 (en) * 1996-10-28 1997-01-08 Sandoz Ltd Organic compounds
JPH11222407A (ja) * 1997-11-14 1999-08-17 Sankyo Co Ltd 新規殺菌剤
US6289745B1 (en) * 1999-05-04 2001-09-18 James Bowers High temperature insertion type flow element and mounting extension
US6689765B2 (en) * 1999-05-04 2004-02-10 Schering Corporation Piperazine derivatives useful as CCR5 antagonists
US7825121B2 (en) * 1999-05-04 2010-11-02 Schering Corporation Piperazine derivatives useful as CCR5 antagonists
US6391865B1 (en) * 1999-05-04 2002-05-21 Schering Corporation Piperazine derivatives useful as CCR5 antagonists
GB0101577D0 (en) * 2001-01-22 2001-03-07 Smithkline Beecham Plc Compounds
AR032920A1 (es) * 2001-03-01 2003-12-03 Smithkline Beecham Corp Compuestos inhibidores de las peptido-deformilasas y medios para tratar infecciones bacterianas utilizando dichos inhibidores
GB0112836D0 (en) * 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
EP1470131A2 (fr) * 2002-01-29 2004-10-27 Glaxo Group Limited Composes aminopiperidine, leur procede de preparation et compositions pharmaceutiques les contenant
TW200409637A (en) * 2002-06-26 2004-06-16 Glaxo Group Ltd Compounds
US7196090B2 (en) * 2002-07-25 2007-03-27 Warner-Lambert Company Kinase inhibitors
TW200427688A (en) 2002-12-18 2004-12-16 Glaxo Group Ltd Antibacterial agents
RU2350615C2 (ru) * 2003-09-22 2009-03-27 Янссен Фармацевтика, Н.В. 7-аминоалкилиденилгетероциклические хинолоны и нафтиридоны
WO2006002047A2 (fr) * 2004-06-15 2006-01-05 Glaxo Group Limited Agents antibacteriens
EP1773831A1 (fr) * 2004-07-08 2007-04-18 Glaxo Group Limited Agents antibacteriens
US7732612B2 (en) * 2004-09-09 2010-06-08 Janssen Pharmaceutica, N.V. 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
MY150958A (en) * 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
US8329694B2 (en) * 2005-06-24 2012-12-11 Toyama Chemical Co., Ltd. Quinoxalinones as antibacterial composition
GB0521563D0 (en) * 2005-10-21 2005-11-30 Glaxo Group Ltd Novel compounds
CA2626641A1 (fr) * 2005-10-21 2007-07-19 Glaxo Group Limited Composes
DE102005050892A1 (de) * 2005-10-21 2007-04-26 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
US20070185153A1 (en) * 2005-12-22 2007-08-09 Nathalie Cailleau Compounds
ATE481406T1 (de) * 2006-04-06 2010-10-15 Glaxo Group Ltd Pyrrolochinoxalinonderivate als antibakterielle mittel
GB0608263D0 (en) * 2006-04-26 2006-06-07 Glaxo Group Ltd Compounds
NZ573032A (en) * 2006-05-26 2010-12-24 Taisho Pharmaceutical Co Ltd Antimicrobial heretocyclic compound and intermediates for its production
GB0613208D0 (en) * 2006-07-03 2006-08-09 Glaxo Group Ltd Compounds
EP1992628A1 (fr) * 2007-05-18 2008-11-19 Glaxo Group Limited Dérivés et analogues de N-éthylquinolones et N-éthylazaquinolones
GB0705672D0 (en) * 2007-03-23 2007-05-02 Glaxo Group Ltd Compounds
EP1980251A1 (fr) * 2007-04-13 2008-10-15 Glaxo Group Limited Derivées de pyrrolo[3,2,1-ij]quinoline-4-one pour traiter la tuberculose
GB0707708D0 (en) * 2007-04-20 2007-05-30 Glaxo Group Ltd Compounds
DE602008002912D1 (de) * 2007-04-20 2010-11-18 Glaxo Group Ltd Tricyclische stickstoffhaltige verbindungen als antibakterielle wirkstoffe
GB0707706D0 (en) * 2007-04-20 2007-05-30 Glaxo Group Ltd Compounds

Also Published As

Publication number Publication date
AR057981A1 (es) 2008-01-09
DE602006012535D1 (de) 2010-04-08
NZ567315A (en) 2011-01-28
HRP20100194T8 (en) 2010-06-30
AU2006335042A1 (en) 2007-07-19
CY1110137T1 (el) 2015-01-14
US20080280892A1 (en) 2008-11-13
EP1954697B1 (fr) 2010-02-24
WO2007081597A3 (fr) 2008-06-12
KR20080064173A (ko) 2008-07-08
WO2007081597A2 (fr) 2007-07-19
DK1954697T3 (da) 2010-06-14
SI1954697T1 (sl) 2010-05-31
CA2626641A1 (fr) 2007-07-19
EA200801128A1 (ru) 2008-10-30
PT1954697E (pt) 2010-05-17
IL190803A0 (en) 2008-12-29
TW200736263A (en) 2007-10-01
NO20082191L (no) 2008-07-16
ATE458737T1 (de) 2010-03-15
PL1954697T3 (pl) 2010-07-30
EP1954697A2 (fr) 2008-08-13
HRP20100194T1 (hr) 2010-05-31
JP2009512695A (ja) 2009-03-26
PE20070793A1 (es) 2007-08-23
HK1118546A1 (en) 2009-02-13
CR9930A (es) 2008-07-29
US20080221110A1 (en) 2008-09-11
ES2340531T3 (es) 2010-06-04
BRPI0617467A2 (pt) 2011-07-26

Similar Documents

Publication Publication Date Title
MA29873B1 (fr) Composes
EA200970987A1 (ru) Трициклические азотсодержащие соединения в качестве антибактериальных агентов
TW200801001A (en) Compounds
GEP20156230B (en) Forms of rifaximin and usage thereof
GB0613208D0 (en) Compounds
EA200900781A1 (ru) 4-фенилпиран-3,5-дионы, 4-фенилтиопиран-3,5-дионы и циклогексантрионы, как новые гербициды
GB2460579A (en) Silylethynylated heteroacenes and electronic devices made therewith
TW200708511A (en) Novel thiophene derivatives
EA201000888A1 (ru) 4-фенилпиран-3,5-дионы, 4-фенилтиопиран-3,5-дионы и 2-фенилциклогексан-1,3,5-трионы в качестве гербицидов
MX2009004883A (es) Piridil sulfoximinas multi-substituidas y su uso como insecticidas.
MA32190B1 (fr) Anticorps dirigés contre l'angiopoïétine 1 et l'angiopoïétine 2 et leur utilisation
IN2014CN03629A (fr)
MY154909A (en) Novel thiophene derivatives
CR8986A (es) Isoxazoles sustituidos como fungicidas
BRPI0717266A2 (pt) Derivados de oxindol
BRPI0514586A (pt) triazolftalazinas
WO2006072612A3 (fr) Triazolophthalazines
CL2007002182S1 (es) Terminal.
DK2410010T3 (da) Forbedrede blyfri isoleringssammensætninger, der indeholder metallocenpolymerer
WO2009077471A3 (fr) Azolylméthyloxiranes, leur utilisation et agents les contenant
EA200870097A1 (ru) Композиция полипропилена, включающая компонент сополимера пропилена
FI20055644A0 (fi) Ryhmäviestintä
MA28348A1 (fr) Pipéridinylcarbonyl-pyrrolidines et leur utilisation comme agonistes de mélanocortine
CO6241120A2 (es) (DIHIDRO)PIRROLO[2,1-á]ISOQUINOLINAS.
EA200800713A1 (ru) Аморфные твёрдые дисперсии